NSHS — Nanosphere Health Sciences Income Statement
0.000.00%
Last trade - 00:00- CA$0.36m
- CA$0.40m
- 26
- 73
- 52
- 48
Annual income statement for Nanosphere Health Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.591 | 0.356 | 0.282 | 0.228 | -0.263 |
| Operating Profit | -0.591 | -0.356 | -0.282 | -0.228 | 0.263 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.591 | -0.356 | -0.282 | -0.228 | 0.263 |
| Net Income After Taxes | -0.591 | -0.356 | -0.282 | -0.228 | 0.263 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.591 | -0.356 | -0.282 | -0.228 | 0.263 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.591 | -0.356 | -0.282 | -0.228 | 0.263 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.103 | -0.056 | -0.027 | -0.022 | -0.023 |